200 related articles for article (PubMed ID: 1372333)
1. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide.
Ilyas AA; Cook SD; Dalakas MC; Mithen FA
J Neuroimmunol; 1992 Mar; 37(1-2):85-92. PubMed ID: 1372333
[TBL] [Abstract][Full Text] [Related]
2. Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide.
Eurelings M; Moons KG; Notermans NC; Sasker LD; De Jager AE; Wintzen AR; Wokke JH; Van den Berg LH
Neurology; 2001 Jan; 56(2):228-33. PubMed ID: 11160960
[TBL] [Abstract][Full Text] [Related]
3. Anti-sulfatide IgM antibodies in peripheral neuropathy: to test or not to test?
Giannotta C; Di Pietro D; Gallia F; Nobile-Orazio E
Eur J Neurol; 2015 May; 22(5):879-82. PubMed ID: 25597226
[TBL] [Abstract][Full Text] [Related]
4. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.
Ilyas AA; Quarles RH; Dalakas MC; Brady RO
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6697-700. PubMed ID: 2413445
[TBL] [Abstract][Full Text] [Related]
5. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes.
Ilyas AA; Dalakas MC; Brady RO; Quarles RH
Brain Res; 1986 Oct; 385(1):1-9. PubMed ID: 2429733
[TBL] [Abstract][Full Text] [Related]
6. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy.
Braun PE; Frail DE; Latov N
J Neurochem; 1982 Nov; 39(5):1261-5. PubMed ID: 6181197
[TBL] [Abstract][Full Text] [Related]
7. Antigenic determinants in IgM paraprotein-related neuropathies.
Nobile-Orazio E
Clin Lymphoma Myeloma; 2009 Mar; 9(1):107-9. PubMed ID: 19362989
[TBL] [Abstract][Full Text] [Related]
8. Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies.
Boso F; Ruggero S; Giannotta C; Benedetti L; Marfia GA; Ermani M; Campagnolo M; Salvalaggio A; Gallia F; De Michelis C; Visentin A; Bianco M; Ruiz M; Mataluni G; Nobile-Orazio E; Briani C
Eur J Neurol; 2017 Nov; 24(11):1334-1340. PubMed ID: 28782863
[TBL] [Abstract][Full Text] [Related]
9. The human anti-myelin-associated glycoprotein IgM system.
Murray N; Page N; Steck AJ
Ann Neurol; 1986 May; 19(5):473-8. PubMed ID: 2424361
[TBL] [Abstract][Full Text] [Related]
10. Anti-MAG IgM antibodies in patients with neuropathy and IgM M proteins: detection by ELISA.
Nobile-Orazio E; Vietorisz T; Messito MJ; Sherman WH; Latov N
Neurology; 1983 Jul; 33(7):939-42. PubMed ID: 6191246
[TBL] [Abstract][Full Text] [Related]
11. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein.
Pestronk A; Li F; Griffin J; Feldman EL; Cornblath D; Trotter J; Zhu S; Yee WC; Phillips D; Peeples DM
Neurology; 1991 Mar; 41(3):357-62. PubMed ID: 1706491
[TBL] [Abstract][Full Text] [Related]
12. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
Drouet A; Caudie C; Vallat JM; Ruel JH; Felten D; Guilloton L; Giraud P
Rev Neurol (Paris); 2006 Jun; 162(6-7):760-6. PubMed ID: 16840988
[TBL] [Abstract][Full Text] [Related]
13. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia.
Weiss MD; Dalakas MC; Lauter CJ; Willison HJ; Quarles RH
J Neuroimmunol; 1999 Mar; 95(1-2):174-84. PubMed ID: 10229128
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
Latov N
Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
[TBL] [Abstract][Full Text] [Related]
15. Mouse monoclonal and rabbit polyclonal antibodies prepared to human myelin-associated glycoprotein also react with glycosphingolipids of peripheral nerve.
Ilyas AA; Dobersen MJ; Willison HJ; Quarles RH
J Neuroimmunol; 1986 Aug; 12(2):99-106. PubMed ID: 2426302
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical studies of human peripheral nerve with serum from patients with polyneuropathy and paraproteinemia.
Abrams GM; Latov N; Hays AP; Sherman W; Zimmerman EA
Neurology; 1982 Aug; 32(8):821-6. PubMed ID: 6285225
[TBL] [Abstract][Full Text] [Related]
17. Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment.
Campagnolo M; Ferrari S; Dalla Torre C; Cabrini I; Cacciavillani M; Lucchetta M; Ruggero S; Toffanin E; Cavallaro T; Briani C
J Neuroimmunol; 2015 Apr; 281():1-4. PubMed ID: 25867460
[TBL] [Abstract][Full Text] [Related]
18. Variability in the structural requirements for binding of human monoclonal anti-myelin-associated glycoprotein immunoglobulin M antibodies and HNK-1 to sphingoglycolipid antigens.
Ilyas AA; Chou DK; Jungalwala FB; Costello C; Quarles RH
J Neurochem; 1990 Aug; 55(2):594-601. PubMed ID: 1695241
[TBL] [Abstract][Full Text] [Related]
19. Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia.
Nobile-Orazio E; Francomano E; Daverio R; Barbieri S; Marmiroli P; Manfredini E; Carpo M; Moggio M; Legname G; Baldini L
Ann Neurol; 1989 Oct; 26(4):543-50. PubMed ID: 2479332
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.
Quarles RH; Ilyas AA; Willison HJ
Chem Phys Lipids; 1986 Dec; 42(1-3):235-48. PubMed ID: 2435424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
